What's new

Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised

May 23, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Zoledronic Acid Accord...

Next Article

Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol...

Related Posts

Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 75, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0

Committee for Medicinal Products for Human Use (CHMP): 19-22 May 2025, European Medicines Agency, Amsterdam, the Netherlands, from 19 May 2025 to 22 May 2025

Committee for Medicinal Products for Human Use (CHMP): ...

May 19, 2025  0